AUTHOR=Fignani Daniela , Licata Giada , Brusco Noemi , Nigi Laura , Grieco Giuseppina E. , Marselli Lorella , Overbergh Lut , Gysemans Conny , Colli Maikel L. , Marchetti Piero , Mathieu Chantal , Eizirik Decio L. , Sebastiani Guido , Dotta Francesco TITLE=SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature JOURNAL=Frontiers in Endocrinology VOLUME=11 YEAR=2020 URL=https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2020.596898 DOI=10.3389/fendo.2020.596898 ISSN=1664-2392 ABSTRACT=
Increasing evidence demonstrated that the expression of Angiotensin I-Converting Enzyme type 2 (ACE2) is a necessary step for SARS-CoV-2 infection permissiveness. In light of the recent data highlighting an association between COVID-19 and diabetes, a detailed analysis aimed at evaluating ACE2 expression pattern distribution in human pancreas is still lacking. Here, we took advantage of INNODIA network EUnPOD biobank collection to thoroughly analyze ACE2, both at mRNA and protein level, in multiple human pancreatic tissues and using several methodologies. Using multiple reagents and antibodies, we showed that ACE2 is expressed in human pancreatic islets, where it is preferentially expressed in subsets of insulin producing